title: [Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].
abstract: One of the important problems in the treatment of patients with inflammatory bowel disease are the persistent complaints of pain, abdominal distention, frequent stools, excretion of mucus with faeces with the presence of endoscopic or roentgenologic remission in the damaged parts of gastrointestinal tract. In this review we describe possible causes of such complaints and some methods of their therapeutic correction.
authors.forename: S S
authors.initials: SS
authors.lastname: Belous
authors.forename: I L
authors.initials: IL
authors.lastname: Khalif
authors.forename: O V
authors.initials: OV
authors.lastname: Golovenko
mesh_terms: D015746:Abdominal Pain / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D007413:Intestinal Mucosa / Q000473:pathology / Q000503:physiopathology; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
chemical_list: D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin